These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 26771239)

  • 1. Fundus Autofluorescence and SD-OCT Document Rapid Progression in Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Associated with a c.256G > A Mutation in BEST1.
    Kellner S; Stöhr H; Fiebig B; Weinitz S; Farmand G; Kellner U; Weber BH
    Ophthalmic Genet; 2016 Jun; 37(2):201-8. PubMed ID: 26771239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Macular Changes in the First Proband of Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Due to a Newly Identified Mutation in BEST1.
    Chen CJ; Kaufman S; Packo K; Stöhr H; Weber BH; Goldberg MF
    Ophthalmic Genet; 2016; 37(1):102-8. PubMed ID: 26849243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel missense mutation in BEST1 associated with an autosomal-dominant vitreoretinochoroidopathy (ADVIRC) phenotype.
    Mano F; LoBue SA; Olsen TW; Marmorstein AD; Pulido JS
    Ophthalmic Genet; 2018 Dec; 39(6):749-753. PubMed ID: 30222024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of family with autosomal recessive bestrophinopathy associated with new BEST1 mutation.
    Kubota D; Gocho K; Akeo K; Kikuchi S; Sugahara M; Matsumoto CS; Shinoda K; Mizota A; Yamaki K; Takahashi H; Kameya S
    Doc Ophthalmol; 2016 Jun; 132(3):233-43. PubMed ID: 27071392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable expressivity of the autosomal dominant vitreoretinochoroidopathy (ADVIRC) phenotype associated with a novel variant in
    Mainguy A; Dhaenens CM; Poncet A; Billaud F; Giraud L; Zanlonghi X; Masse H; Le Meur G
    Ophthalmic Genet; 2024 Oct; 45(5):470-475. PubMed ID: 38957071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
    Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
    Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BESTROPHINOPATHY: A Spectrum of Ocular Abnormalities Caused by the c.614T>C Mutation in the BEST1 Gene.
    Toto L; Boon CJ; Di Antonio L; Battaglia Parodi M; Mastropasqua R; Antonucci I; Stuppia L; Mastropasqua L
    Retina; 2016 Aug; 36(8):1586-95. PubMed ID: 26716959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel BEST1 Mutation in Autosomal Recessive Bestrophinopathy.
    Lee CS; Jun I; Choi SI; Lee JH; Lee MG; Lee SC; Kim EK
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8141-50. PubMed ID: 26720466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive Cone Dysfunction and Geographic Atrophy of the Macula in Late Stage Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC).
    Chen CJ; Goldberg MF
    Ophthalmic Genet; 2016; 37(1):81-5. PubMed ID: 24564716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New best1 mutations in autosomal recessive bestrophinopathy.
    Fung AT; Yzer S; Goldberg N; Wang H; Nissen M; Giovannini A; Merriam JE; Bukanova EN; Cai C; Yannuzzi LA; Tsang SH; Allikmets R
    Retina; 2015 Apr; 35(4):773-82. PubMed ID: 25545482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term changes in autosomal dominant vitreoretinochoroidopathy (ADVIRC).
    Wöster L; Roider J
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):441-442. PubMed ID: 28975401
    [No Abstract]   [Full Text] [Related]  

  • 12. BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies.
    Vincent A; McAlister C; Vandenhoven C; Héon E
    Eye (Lond); 2011 Jan; 25(1):113-8. PubMed ID: 21072067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AUTOSOMAL DOMINANT VITREORETINOCHOROIDOPATHY: When Molecular Genetic Testing Helps Clinical Diagnosis.
    Boulanger-Scemama E; Sahel JA; Mohand-Said S; Antonio A; Condroyer C; Zeitz C; Audo I
    Retina; 2019 May; 39(5):867-878. PubMed ID: 29370033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared fundus autofluorescence in subclinical best vitelliform macular dystrophy.
    Parodi MB; Iacono P; Del Turco C; Bandello F
    Am J Ophthalmol; 2014 Dec; 158(6):1247-1252.e2. PubMed ID: 25174897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic Mutations in the BEST1 Gene: Additional Families with Autosomal Recessive Bestrophinopathy.
    Wivestad Jansson R; Berland S; Bredrup C; Austeng D; Andréasson S; Wittström E
    Ophthalmic Genet; 2016 Jun; 37(2):183-93. PubMed ID: 26333019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular phenotype analysis of a family with biallelic mutations in the BEST1 gene.
    Sharon D; Al-Hamdani S; Engelsberg K; Mizrahi-Meissonnier L; Obolensky A; Banin E; Sander B; Jensen H; Larsen M; Schatz P
    Am J Ophthalmol; 2014 Mar; 157(3):697-709.e1-2. PubMed ID: 24345323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-vasogenic cystoid maculopathy in autosomal recessive bestrophinopathy: novel insights from NIR-FAF and OCTA imaging.
    Bianco L; Arrigo A; Antropoli A; Saladino A; Aragona E; Bandello F; Parodi MB
    Ophthalmic Genet; 2024 Feb; 45(1):44-50. PubMed ID: 37041716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
    Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I
    Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1.
    Schatz P; Bitner H; Sander B; Holfort S; Andreasson S; Larsen M; Sharon D
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4754-65. PubMed ID: 20375334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1.
    Johnson AA; Lee YS; Chadburn AJ; Tammaro P; Manson FD; Marmorstein LY; Marmorstein AD
    Exp Eye Res; 2014 Apr; 121():74-85. PubMed ID: 24560797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.